课题基金 / 基金详情

Molecular bases of leucine rich repeat kinase 2 activity regulation

Molecular bases of leucine rich repeat kinase 2 activity regulation
富含亮氨酸重复激酶2活性调节的分子基础
批准号:
9106756
负责人:
Quyen Quoc Hoang
金额:
$57.23万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-01 至 2020-05-31

项目摘要

项目成果

Quyen Quoc Hoang的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):工作说明书。在这项多PI应用中提出的研究中,有三名PI(Hoang,Yue和Ubarretxena博士)结合了三个不同实验室的努力,以研究富含亮氨酸重复序列激酶2(LRRK 2)的结构和活性调节。这种独特的多结构域酶中的突变与帕金森病(PD)发病机制有关,因此LRRK 2已经成为治疗这种神经退行性疾病的关键治疗靶标。从携带PD连锁突变的GTRK结构域和COR区域的X射线晶体结构获得的结果(Dr. Hoang组分)和从全长LRRK 2的高分辨率电子显微镜3-D模型获得的结果(Dr. Ubarretxena组分)将用于通知生物化学、基于细胞的和动物研究(Dr. Yue组分)。特别是,我们将学习如何在LRRK 2中的GTdR和激酶活性是协调的,以及如何在酶中的结构域-结构域相互作用,和PD连锁突变影响这些活动。
英文摘要
 DESCRIPTION (provided by applicant): Statement of Work. The research proposed in this multi-PI application with three PIs (Drs. Hoang, Yue and Ubarretxena) combines the efforts of three different laboratories to study the structure and activity regulation of Leucine Rich Repeat Kinase 2 (LRRK2). Mutations in this unique multi- domain enzyme have been linked with Parkinson's disease (PD) pathogenesis, and thus LRRK2 has emerged as a key therapeutic target for the treatment of this neurodegenerative disorder. The results obtained from X-ray crystal structures of the GTPase domain and the COR region carrying PD-linked mutations (Dr. Hoang component) and those obtained from the high- resolution electron microscopy 3-D models of full-length LRRK2 (Dr. Ubarretxena component) will be used to inform the biochemical, cell-based and animal studies (Dr. Yue component). In particular, we will learn how the GTPase and kinase activities in LRRK2 are coordinated and how domain-domain interactions in the enzyme, and PD-linked mutations affect these activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanism of the Parkinson's Disease-associated protein LRRK2
Molecular Mechanism of the Parkinson's Disease-associated protein LRRK2
Molecular bases of leucine rich repeat kinase 2 activity regulation
Structure and Function of the Parkinson's disease associated protein LRRK2
海外基金